Orange Book product · Generic (ANDA)
TAFLUPROST
TAFLUPROST
Generic (ANDA)ANDA 209040TE ATRX SANDOZ
At a glance
Jan 28, 2022
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 28, 2022
4 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
TAFLUPROST
Strength
0.0015%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AT
Application
ANDA 209040
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of TAFLUPROST
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
